| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, See Remarks | Director, 10% Owner, See Remarks
1 company
Foundation Fighting Blindness Retinal Degeneration Fund is a Director, See Remarks at Opus Genetics, Inc.. Recent SEC Form 4 filings include 0 buys and 2 sells.
Estimated insider holdings value: $15.6M based on current market prices.